Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidade Federal Fluminense

About this trial

The study aims to evaluate the effect of ginger supplementation on inflammatory cytokines and markers of oxidative stress in patients with Coronary Artery Disease (CAD). A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.

Eligibility criteria

Qualifiers

Both sexes

Over 18 years of age;

Diagnosed with Coronary Artery Disease: confirmed by coronary angiography, coronary computed tomography angiography, or functional testing with ischemic load);

Participants who are asymptomatic or have angina limited to functional class III will be considered;

Disqualifiers

Unstable Coronary Artery Disease;

Pre-operative coronary artery bypass grafting or awaiting elective angioplasty;

Unstable angina;

NYHA functional class III or higher;

Trial design

Treatments tested in this trial

  • Ginger
  • Placebo

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Universidade Federal Fluminense

Lead sponsor

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Collaborator

Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Collaborator